Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. The company reported $1.95 thousand in sales this quarter.
Heart Test Laboratories Q3 EPS $(0.16) Beats $(0.22) Estimate, Sales $1.95K
Heart Test Laboratories (NASDAQ:HSCS) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.22) by 27.27 percent. The company reported $1.95 thousand in sales this quarter.
Related Posts
Recap: AFC Gamma Q3 Earnings
AFC Gamma (NASDAQ:AFCG) reported its Q3 earnings results on Wednesday, November 8, 2023 at 08:32 AM. Here’s what…
Intelligent Bio Solutions Announces UK-Wide Glass Manufacturer To Roll Out Non-Invasive Drug Screening System Across UK Operations
Intelligent Bio Solutions Inc. (NASDAQ:INBS) (the "Company"), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point of care,
Meta’s Massive $1B Bet On Nvidia H100 GPU Cluster Will Dwarf Every Other Company’s Target, But Zuckerberg Reveals Original Goal Was This, Not AI
Meta Platforms CEO Mark Zuckerberg spilled the beans on what was behind the company's decision to buy 350,000 Nvidia H100 GPUs.